{"public_id":"cl_46211c0f8f1b72c99abd0c69bfde5f24","status":"active","superseded_by_public_id":null,"corpus_id":13512160,"text":"Among live births to women with epilepsy exposed to antiepileptic drugs, the overall major congenital malformation rate was 4.2%.","confidence":0.99,"paper":{"corpus_id":13512160,"title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","url":"https://sah.borca.ai/papers/13512160"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.99,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_a224769b046c379b909a8bede6e6e113","name":"antiepileptic drug exposure","description":"In utero exposure to antiepileptic medications during pregnancy.","types":["exposure"],"url":"https://sah.borca.ai/concepts/co_a224769b046c379b909a8bede6e6e113"},{"public_id":"co_b41da2012af71c5e3f7c6d824de0be69","name":"women with epilepsy","description":"Pregnant women diagnosed with epilepsy and included in the pregnancy register.","types":["population"],"url":"https://sah.borca.ai/concepts/co_b41da2012af71c5e3f7c6d824de0be69"},{"public_id":"co_dc47d7bc8b2b2a7cf364997911d538c3","name":"major congenital malformation","description":"A serious structural abnormality present at birth and recorded as the primary outcome in early infancy.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_dc47d7bc8b2b2a7cf364997911d538c3"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_46211c0f8f1b72c99abd0c69bfde5f24"}